Classys Inc
KOSDAQ:214150
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
28 400
61 900
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Classys Inc
Cost of Revenue
Classys Inc
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
Classys Inc
KOSDAQ:214150
|
Cost of Revenue
-₩44.3B
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
|
Dentium Co Ltd
KRX:145720
|
Cost of Revenue
-₩134.7B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
|
B
|
Biodyne Co Ltd
KOSDAQ:314930
|
Cost of Revenue
-₩3.4B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
|
J
|
Jeisys Medical Inc
KOSDAQ:287410
|
Cost of Revenue
-₩50.7B
|
CAGR 3-Years
-64%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
L
|
Lutronic Corp
KOSDAQ:085370
|
Cost of Revenue
-₩96.6B
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-14%
|
|
|
V
|
Viol Co Ltd
KOSDAQ:335890
|
Cost of Revenue
-₩9.5B
|
CAGR 3-Years
-38%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Classys Inc
Glance View
Classys Inc., a South Korean powerhouse in the world of aesthetic medical devices, has carved a niche for itself by capitalizing on the soaring demand for non-invasive beauty treatments. Founded in 2007, the company quickly identified a growing market shift towards minimally invasive procedures, and leveraged its technological prowess to develop cutting-edge solutions. Focusing on continuous innovation, Classys has developed a robust portfolio of high-quality products, including popular devices like Clatuu Alpha for fat reduction and Ultraformer for skin lifting. These devices cater to clinics and professionals seeking reliable, effective solutions for their clients' aesthetic needs. The company strategically invests in research and development to stay ahead in this highly competitive sector, continually upgrading its offerings to suit market trends. Operating in over 60 countries, Classys has effectively harnessed the power of global distribution networks and strategic partnerships to bolster its market presence. The company's business model primarily revolves around direct sales and distribution agreements, generating revenue by selling advanced aesthetic devices to medical professionals, clinics, and distributors worldwide. By providing training and after-sales services, Classys ensures customer satisfaction and fosters long-term relationships, which are crucial for repeat business. Additionally, its strong emphasis on compliance with international safety standards and certifications has bolstered its reputation, enabling the company to expand its footprint in emerging markets. This strategic approach has allowed Classys to maintain steady growth in an industry where technological advancements and consumer preferences are in constant flux.
See Also
What is Classys Inc's Cost of Revenue?
Cost of Revenue
-44.3B
KRW
Based on the financial report for Sep 30, 2024, Classys Inc's Cost of Revenue amounts to -44.3B KRW.
What is Classys Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-22%
Over the last year, the Cost of Revenue growth was -14%. The average annual Cost of Revenue growth rates for Classys Inc have been -28% over the past three years , -22% over the past five years .
You don't have any saved screeners yet
